Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in J Immunol

Retrieve available abstracts of 11 articles:
HTML format

Single Articles

    June 2022
  1. LIU Y, Qin L, Wang J, Xie X, et al
    miR-146a Maintains Immune Tolerance of Kupffer Cells and Facilitates Hepatitis B Virus Persistence in Mice.
    J Immunol. 2022;208:2558-2572.
    PubMed     Abstract available

    January 2022
  2. WANG X, Liang Y, Wang H, Zhang B, et al
    The Protective Role of IL-36/IL-36R Signal in Con A-Induced Acute Hepatitis.
    J Immunol. 2022 Jan 19. pii: jimmunol.2100481. doi: 10.4049/jimmunol.2100481.
    PubMed     Abstract available

  3. LI W, Duan X, Zhu C, Liu X, et al
    Hepatitis B and Hepatitis C Virus Infection Promote Liver Fibrogenesis through a TGF-beta1-Induced OCT4/Nanog Pathway.
    J Immunol. 2022 Jan 12. pii: jimmunol.2001453. doi: 10.4049/jimmunol.2001453.
    PubMed     Abstract available

    August 2021
  4. MAZOUZ S, Boisvert M, Abdel-Hakeem MS, Khedr O, et al
    Expansion of Unique Hepatitis C Virus-Specific Public CD8(+) T Cell Clonotypes during Acute Infection and Reinfection.
    J Immunol. 2021 Aug 2. pii: jimmunol.2001386. doi: 10.4049/jimmunol.2001386.
    PubMed     Abstract available

    April 2021
  5. BARRIOCANAL M, Prior C, Suarez B, Unfried JP, et al
    Long Noncoding RNA EGOT Responds to Stress Signals to Regulate Cell Inflammation and Growth.
    J Immunol. 2021;206:1932-1942.
    PubMed     Abstract available

    January 2021
  6. BARRAGUE H, Fontaine J, Abravanel F, Maure E, et al
    Mobilization of gammadelta T Cells and IL-10 Production at the Acute Phase of Hepatitis E Virus Infection in Cytomegalovirus Carriers.
    J Immunol. 2021 Jan 22. pii: jimmunol.2000187. doi: 10.4049/jimmunol.2000187.
    PubMed     Abstract available

  7. RODRIGUEZ-GARCIA E, Zabaleta N, Gil-Farina I, Gonzalez-Aparicio M, et al
    AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral Therapy That Required Both Type I IFN and TNF-alpha Production.
    J Immunol. 2021;206:376-385.
    PubMed     Abstract available

  8. XU L, Yu D, Yao YL, Gu T, et al
    Correction: Tupaia MAVS Is a Dual Target during Hepatitis C Virus Infection for Innate Immune Evasion and Viral Replication via NF-kappaB.
    J Immunol. 2021 Jan 13. pii: jimmunol.2001396. doi: 10.4049/jimmunol.2001396.

    September 2020
  9. XU L, Yu D, Yao YL, Gu T, et al
    Tupaia MAVS Is a Dual Target during Hepatitis C Virus Infection for Innate Immune Evasion and Viral Replication via NF-kappaB.
    J Immunol. 2020 Sep 9. pii: jimmunol.2000376. doi: 10.4049/jimmunol.2000376.
    PubMed     Abstract available

    July 2020
  10. GRAVES AM, Virdis F, Morrison E, Alvaro-Benito M, et al
    Human Hepatitis B Viral Infection Outcomes Are Linked to Naturally Occurring Variants of HLA-DOA That Have Altered Function.
    J Immunol. 2020 Jul 20. pii: jimmunol.2000476. doi: 10.4049/jimmunol.2000476.
    PubMed     Abstract available

    June 2020
  11. JING ZT, Liu W, Wu SX, He Y, et al
    Correction: Hepatitis B Virus Surface Antigen Enhances the Sensitivity of Hepatocytes to Fas-Mediated Apoptosis via Suppression of AKT Phosphorylation.
    J Immunol. 2020 Jun 1. pii: jimmunol.2000441. doi: 10.4049/jimmunol.2000441.

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.